Clint Tomlinson | Investor Relations |
Christopher Missling | President and Chief Executive Officer |
Sandra Boenisch | Principal Financial Officer |
Ram Selvaraju | H.C. Wainwright |
Anna Vorobyeva | Roth Capital Partners |
Tom Bishop | BI Research |
Welcome to the Anavex Life Sciences Fiscal 2019 Second Quarter Financial Results and Corporate Update Conference Call. My name is Vanessa and I will be your operator for today. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over to your host, Clint Tomlinson.